BTK and B-cell non-Hodgkin lymphoma: PLS-123′s potent anti-proliferative and pro-apoptotic effects in a wide range of B-cell lymphoma subtypes may be attributed to dual-action Btk inhibitory mode and alternative selectivity profile provided additional anti-tumor mechanisms.